Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care-Reference-Cited by-同舟云学术

Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care

Published:2009-03-29 Issue:4 Volume:11 Page:354-360
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Alehagen Urban¹,Dahlström Ulf¹,Lindahl Tomas L.²

Affiliation:

1. Department of Cardiology; Heart Center, Linköping University Hospital; SE-581 85 Linkoping Sweden

2. Department of Clinical Chemistry; Laboratory Medicine Östergötland and Institute of Biomedicine and Surgery, Linköping University Hospital; SE-581 85 Sweden

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study;McAlister;Circulation,2004

2. When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the ‘cardio-renal syndrome’?;Kimmenade;Eur Heart J,2007

3. Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction?;Kimmenade;J Am Coll Cardiol,2006

4. Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure;Gardner;Eur Heart J,2007

5. Biological variation of cystatin C: implications for the assessment of glomerular filtration rate;Keevil;Clin Chem,1998

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Characteristics and Features of Idiopathic Premature Ventricular Contractions with an Enlarged Left Atrium in Patients Without Structural Heart Diseases;Cardiovascular Innovations and Applications;2024

2. Diastolische Dysfunktion und HFpEF bei CKD;Die Nephrologie;2023-09-18

3. Cystatin C as Predictor of Long-Term Mortality in Elderly: a Systematic Review and Meta-Analysis;SN Comprehensive Clinical Medicine;2022-07-26

4. Cystatin C and Its Temporal Change May Predict Development and Recovery of Cardio-renal Syndrome Type 1 in Acute Heart Failure;e-Journal of Cardiovascular Medicine;2022-06-01

5. New aspects in cardiorenal syndrome and HFpEF;Clinical Kidney Journal;2022-05-06